Peer Review reports
From: Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
| Original Submission | ||
|---|---|---|
| 14 Dec 2020 | Submitted | Original manuscript |
| 4 Jan 2021 | Reviewed | Reviewer Report |
| 1 Mar 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 2 | ||
| 1 Mar 2021 | Submitted | Manuscript version 2 |
| 3 Mar 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 3 | ||
| 3 Mar 2021 | Submitted | Manuscript version 3 |
| 26 Mar 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 4 | ||
| 26 Mar 2021 | Submitted | Manuscript version 4 |
| 31 Mar 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 5 | ||
| 31 Mar 2021 | Submitted | Manuscript version 5 |
| 6 May 2021 | Reviewed | Reviewer Report |
| 18 May 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 6 | ||
| 18 May 2021 | Submitted | Manuscript version 6 |
| 25 May 2021 | Author responded | Author comments - Liza Cholin |
| Resubmission - Version 7 | ||
| 25 May 2021 | Submitted | Manuscript version 7 |
| Publishing | ||
| 31 May 2021 | Editorially accepted | |
| 15 Jul 2021 | Article published | 10.1186/s12882-021-02449-0 |
You can find further information about peer review here.